(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

122022026659

Em AnáliseUtility ModelPCT · US2014030635

Application data

Number

122022026659

Type

Utility Model

Filing

03/17/2014

Publication

-

PCT

US2014030635

Progress at the INPI

  1. Filing03/17/14
  2. Publication
  3. Examination
  4. Allowance03/07/23
  5. Grant05/16/23
  6. In force03/17/29

The patent was granted on 05/16/2023 and is in force until 03/17/2029. Until then, no one may make, use or sell the invention in Brazil without the owner's authorisation.

Protection valid until:03/17/2029

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/06/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

OCUPHIRE PHARMA, INC.

US

REXAHN PHARMACEUTICALS, INC.

US

Inventors

D. K. (pessoa física)

US

E. F. (pessoa física)

IL

H. Y. (pessoa física)

CN

J. C. (pessoa física)

GB

J. C. (pessoa física)

GB

L. P. (pessoa física)

GB

P. D. (pessoa física)

GB

V. P. (pessoa física)

US

Y. W. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

61/800,475 · 03/15/2013

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Alteração de sede deferida

#25.7

08/06/2024

RPI 2796

Alteração de nome deferida

#25.4

07/23/2024

RPI 2794

Concessão da patente

#16.1

Prazo de Validade: 20 (vinte) anos contados a partir de 17/03/2014, observadas as condições legais

05/16/2023

RPI 2732

Deferimento

#9.1

03/07/2023

RPI 2722

Notificação de pedido dividido

#2.4

02/14/2023

RPI 2719

Requerimento de pedido de patente

#2.10

Número de Protocolo '870220122160' em 26/12/2022 16:38 (WB)

01/10/2023

RPI 2714

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.